Artal Group S.A. - CEREVEL THERAPEUTICS HLDNG I ownership

Quarter-by-quarter ownership
Artal Group S.A. ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2021$1,145,000
+233.8%
79,6000.0%0.02%
+283.3%
Q1 2021$343,000
-23.8%
79,6000.0%0.01%
-40.0%
Q4 2020$450,00079,6000.01%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q3 2023
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 72,466$312,0000.11%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 459,215$1,979,0000.08%
Monashee Investment Management LLC 99,998$431,0000.07%
Governors Lane LP 196,034$845,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 166,332$702,0000.05%
Context Capital Management, LLC 82,868$357,0000.04%
EQUITEC SPECIALISTS, LLC 35,825$154,0000.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 166,666$718,0000.02%
RA Capital Management 233,333$1,006,0000.02%
Logos Global Management LP 33,333$144,0000.01%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders